Pfizer Inc. recalls RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b)
Pfizer recalls RELPAX 40mg tablets (NDC 0049-2340-45/0049-2340-05) due to microbial contamination with Burkholderia and Pseudomonas. Stop using if you have these specific packaging.
Lower-risk recall
Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.
Contact the company & request your remedy
What happened, in plain English
Pfizer is recalling RELPAX 40mg tablets that may contain harmful bacteria. This contamination could cause illness if taken, so affected users should stop using the product. Read more at govinfonow.com/recall/38085-pfizer-relpax-40mg-tablets-recall-microbial-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/38085-pfizer-relpax-40mg-tablets-recall-microbial-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1845-2019
Cite this page
“Pfizer RELPAX 40mg Tablets Recall: Microbial Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38085-pfizer-relpax-40mg-tablets-recall-microbial-contamination-risk. Based on FDA recall #D-1845-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1845-2019%22&limit=1).
Why it’s dangerous
The tablets were contaminated with Burkholderia and Pseudomonas bacteria during manufacturing. These bacteria can cause infections if the medication is ingested, but the risk is low for most users.
Who’s affected
People who have the specific 40mg RELPAX tablets with the listed NDC numbers and lot numbers. Those who have taken the product recently are most at risk.
How to tell if you have this one
Check for RELPAX 40mg tablets in 6-count or 12-count packs with NDC numbers 0049-2340-45 or 0049-2340-05. The lot numbers are AR5407 (expiring Feb 2022) or CD4565 (expiring Feb 2022).
- Brand
Pfizer- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC numbers 0049-2340-45 or 0049-2340-05 on the packaging.
Stop Using if Affected
If you have the recalled tablets, stop using them immediately and contact Pfizer for instructions.
Questions people ask
Why is this product being recalled?
Pfizer recalls these RELPAX tablets due to contamination with Burkholderia and Pseudomonas bacteria during manufacturing.
What should I do if I have the recalled product?
Stop using the product immediately and contact Pfizer for instructions on how to handle it.
Are there any specific lot numbers I should check?
Yes, the recalled products have lot numbers AR5407 (expiring Feb 2022) or CD4565 (expiring Feb 2022).
Contact Pfizer
We’ve drafted a message you can send Pfizer to request your refund or repair — edit it as you like.
Subject: Recall D-1845-2019 — Pfizer Pfizer Hello, I own a Pfizer that is covered by recall D-1845-2019 from Pfizer. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1845-2019 (August 14, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1845-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.